KLHL12/C3IP1 Antibody [DyLight 680]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-49927FR
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunoprecipitation, Western Blot (Negative)
Label
DyLight 680 (Excitation = 692 nm, Emission = 712 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
The immunogen for this product maps to a region between residue 150 and 200 of human Kelch-Like 12 using the numbering given in entry NP_067646.1 (GeneID 59349).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for KLHL12/C3IP1 Antibody [DyLight 680]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot (Negative)
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: KLHL12/C3IP1
Alternate Names
C3IP1kelch-like protein 12, CUL3-interacting protein 1, DKIR, FLJ27152, kelch-like 12 (Drosophila), kelch-like protein C3IP1
Gene Symbol
KLHL12
Additional KLHL12/C3IP1 Products
Product Documents for KLHL12/C3IP1 Antibody [DyLight 680]
Product Specific Notices for KLHL12/C3IP1 Antibody [DyLight 680]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...